FDA Releases Guidance for Industry on In Vivo Drug Metabolism Studies

Summary

The FDA has published a guidance document outlining recommendations for sponsors of new drug applications and biologics license applications on conducting in vivo drug metabolism and interaction studies, emphasizing the importance of defining a drug's metabolism during development and assessing its interactions with other medications.